Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Esketamine
Spravato
Not routinely available
SMC (SMC2539)
30/11/2022
Indication
Co-administered with oral antidepressant therapy, in adults with a moderate to severe episode of Major Depressive Disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.
Therapeutic Area
Central nervous system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
28mg nasal spray, solution
Comments
November 2022 - Not routinely available as not recommended for use in NHSScotland
Link to Advice
Advice Published
07/11/2022
SMC Submission Type
Non submission
SMC Status
Not recommended